HIV Vaccine

The development to make HIV vaccines for both the prevention and treatment of HIV infection is ongoing. Some individuals with HIV infection produce antibodies which suppress the virus and allow the patients to remain asymptomatic, suggesting that a vaccine may be achievable. Find the latest research on HIV vaccines here.

July 28, 2020
Review
Open Access

Second career of a biosynthetic enzyme: Lumazine synthase as a virus-like nanoparticle in vaccine development

Biotechnology Reports
Rudolf Ladenstein, Ekaterina Morgunova
August 7, 2020
Review
Open Access

Dissecting the antibody-OME: past, present, and future

Current Opinion in Immunology
Carolin LoosGalit Alter
July 30, 2020
Review

Reverse genetics approaches for the development of mammarenavirus live-attenuated vaccines

Current Opinion in Virology
Chengjin YeLuis Martinez-Sobrido
August 3, 2020
Open Access

New chimeric TLR7/NOD2 agonist is a potent adjuvant to induce mucosal immune responses

EBioMedicine
Alice GutjahrStéphane Paul
August 6, 2020
Open Access

Ensuring the Safety of Yellow Fever Vaccination in Travelers-The Experience at a Large U.S. Academic Medical Center in Colorado

Tropical Medicine and Infectious Disease
Mehdi BandaliAndrés F Henao-Martínez
July 31, 2020
Preprint
Open Access

New Pathways of Mutational Change in SARS-CoV-2 Proteomes Involve Regions of Intrinsic Disorder Important for Virus Replication and Release

BioRxiv : the Preprint Server for Biology
T. TomaszewskiGustavo Caetano-Anolles
August 5, 2020

The Pre-exposure Prophylaxis (PrEP) Care Cascade in People Who Inject Drugs: A Systematic Review

AIDS and Behavior
Colleen B MistlerRoman Shrestha
July 30, 2020
Review
Open Access

Implementing a Status-Neutral Approach to HIV in the Asia-Pacific

Current HIV/AIDS Reports
Nittaya PhanuphakPraphan Phanuphak
August 5, 2020
Open Access

Characterizing PrEP Awareness and Interest Among Filipina Transgender Women

AIDS Education and Prevention : Official Publication of the International Society for AIDS Education
Arjee J RestarDon Operario
July 30, 2020

Anti-HIV/SIV activity of icariin and its metabolite anhydroicaritin mainly involve reverse transcriptase

European Journal of Pharmacology
Yanzheng XieJinyang He
August 1, 2020

Topical Tenofovir Pre-exposure Prophylaxis and Mucosal HIV-Specific Fc-Mediated Antibody Activities in Women

Frontiers in Immunology
Kimone Leigh FisherDerseree Archary
August 5, 2020
Open Access

Optimizing immunization protocols to elicit broadly neutralizing antibodies

Proceedings of the National Academy of Sciences of the United States of America
Kayla G SprengerArup K Chakraborty
July 31, 2020
Open Access

COVID-19: Understanding the science of antibody testing and lessons from the HIV epidemic

Diagnostic Microbiology and Infectious Disease
Stanley H Weiss, Gary P Wormser
August 5, 2020

Induction of E. coli-derived endonuclease MazF suppresses HIV-1 production and causes apoptosis in latently infected cells

Biochemical and Biophysical Research Communications
Mika OkamotoMasanori Baba
July 28, 2020

The contexts of housing stability and change among HIV-positive persons in the Lower Manya Krobo Municipality, Ghana

Health Promotion International
Adobea Y OwusuEric Y Tenkorang

Sign up to follow this feed and discover related papers.

Related Feeds

AIDS Malignancies

HIV infection increases the risk of non-communicable diseases common in the aged, including cardiovascular disease, neurocognitive decline, non-aids malignancies, osteoporosis, and frailty. Discover the latest research in AIDS malignancies.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Acute viral rhinopharyngitis

Acute viral rhinopharyngitis, also known as "common cold", is an acute, self-limiting viral infection of the upper respiratory tract involving the nose, sinuses, pharynx and larynx. Discover the latest research on acute viral rhinopharyngitis here.

African Trypanosomiasis

African trypanosomiasis, also known as sleeping sickness, is an insect-borne parasitic disease of humans and other animals. It is caused by protozoa of the species Trypanosoma brucei and almost invariably progresses to death unless treated. Discover the latest research on African trypanosomiasis here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

© 2020 Meta ULC. All rights reserved
/feed-previews/hiv-vaccine/b02b5e31-f186-4aa3-b3ad-bc6ca29b5ef5